Growth plate cartilage as developmental model in osteoarthritis research - Potentials and limitations

被引:17
作者
Aigner, T.
Gerwin, N.
机构
[1] Univ Leipzig, Inst Pathol, D-0341 Leipzig, Germany
[2] Novartis Inst BioMed Res, Bone & Cartilage Program, Basel, Switzerland
关键词
drug development; chondrocytes; SOX; MMP; cartilage; collagen degradation;
D O I
10.2174/138945007779940052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene expression analysis including large scale gene expression profiling has become a very basic tool for investigating the pathogenesis of degenerative joint diseases as well as for the search of new drug targets. However, gene expression analysis so far revealed very complex expression patterns rather than a clear picture of molecular changes occurring during the initiation and progression of the disease. To elucidate the molecular changes in osteoarthritis the analysis of the fetal growth plate as a developmental model for phenotypic changes in chondrocytes occurring in osteoarthritis can help in three ways: it allows to interpret gene expression patterns in the context of disease-relevant processes also occurring in developing cartilage (e.g. cell differentiation, proliferation, matrix synthesis, catabolism and calcification), it offers the chance to investigate gene function in these functional contexts by knocking out or overexpressing genes in animals, and it provides a suitable model for testing the effect of therapeutic compounds on these processes within the growing cartilage.
引用
收藏
页码:377 / 385
页数:9
相关论文
共 98 条
  • [11] Functional genomics of osteoarthritis
    Aigner, T
    Bartnik, E
    Zien, A
    Zimmer, R
    [J]. PHARMACOGENOMICS, 2002, 3 (05) : 635 - 650
  • [12] Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P1304, DOI 10.1002/1529-0131(200106)44:6<1304::AID-ART222>3.0.CO
  • [13] 2-T
  • [14] TYPE-X COLLAGEN EXPRESSION IN OSTEOARTHRITIC AND RHEUMATOID ARTICULAR-CARTILAGE
    AIGNER, T
    REICHENBERGER, E
    BERTLING, W
    KIRSCH, T
    STOSS, H
    VONDERMARK, K
    [J]. VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1993, 63 (04) : 205 - 211
  • [15] Apoptosis and cellular vitality - Issues in osteoarthritic cartilage degeneration
    Aigner, T
    Kim, HA
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (08): : 1986 - 1996
  • [16] The transcrintion factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6
    Akiyama, H
    Chaboissier, MC
    Martin, JF
    Schedl, A
    de Crombrugghe, B
    [J]. GENES & DEVELOPMENT, 2002, 16 (21) : 2813 - 2828
  • [17] Interactions between Sox9 and β-catenin control chondrocyte differentiation
    Akiyama, H
    Lyons, JP
    Mori-Akiyama, Y
    Yang, XH
    Zhang, R
    Zhang, ZP
    Deng, JM
    Taketo, MM
    Nakamura, T
    Behringer, RR
    McCrea, PD
    de Crombrugghe, B
    [J]. GENES & DEVELOPMENT, 2004, 18 (09) : 1072 - 1087
  • [18] Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro
    Bau, B
    Gebhard, PM
    Haag, J
    Knorr, T
    Bartnik, E
    Aigner, T
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (10): : 2648 - 2657
  • [19] Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization
    Bi, WM
    Huang, WD
    Whitworth, DJ
    Deng, JM
    Zhang, ZP
    Behringer, RR
    de Crombrugghe, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) : 6698 - 6703
  • [20] Sox9 is required for cartilage formation
    Bi, WM
    Deng, JM
    Zhang, ZP
    Behringer, RR
    de Crombrugghe, B
    [J]. NATURE GENETICS, 1999, 22 (01) : 85 - 89